When Do Sunscreens, Acne, & Antibacterial Products Become OTC Drugs in the US?
Analyzing the FDA regulatory division between cosmetics and OTC drugs. Detailing compliance upgrades when products add sunscreen/acne claims.
In the U.S., classification as a cosmetic or OTC drug depends on "intended use" and "active ingredients." Products claiming sunscreen protection, acne treatment, or antibacterial properties, or containing active drugs (salicylic acid, zinc oxide, ethanol), are regulated as OTC drugs. They must comply with drug monographs, obtain NDC codes, and meet 21 CFR 211 GMP rules, rather than MoCRA cosmetics rules.
1. Applicability & Scope
Applies to manufacturers and brand owners exporting sunscreen creams, acne cleansers, antibacterial hand sanitizers, and anti-hair-loss shampoos to the U.S. It does not apply to these products in the EU or China, where they are regulated under cosmetic frameworks (e.g. EU sunscreens are cosmetics, not OTC drugs).
2. Regulatory Basis & Standards
Based on U.S. Federal Regulations 21 CFR Part 201 (labeling), 21 CFR Parts 210/211 (pharmaceutical GMP), and the respective U.S. FDA OTC Drug Monographs.
3. Common Industry Misconceptions
Common myths: First, thinking "printing 'cosmetics' on the package and shipping it as skincare avoids OTC drug regulation". Intended Use controls classification. An anti-aging cream with SPF 15 is legally a drug in the U.S. Second, believing "MoCRA facility registration allows manufacturing of sunscreens". Facilities producing OTC items must register as drug establishments and meet 21 CFR 211 GMP rules.
4. Required Documents Checklist
When a cosmetic product is classified as a U.S. OTC drug, the following dossiers are required:
- Batch Assay analysis reports verifying active ingredient concentrations
- Drug Facts label design formatted exactly to 21 CFR 201.66 specs
- Pharma-grade purified water system validation and micro-testing data
- National Drug Code (NDC) obtained from the FDA Drug Registration portal
5. How QTC Can Support
QTC evaluates formulations for OTC crossover risks, reviews Drug Facts label layouts, and audits plants for 21 CFR 211 gaps. The project aligns NDC codes, FDA DRLS registration files, labels, and GMP evidence.
6. Project Timeline & Process
Timeline: 1. Formulation and claim review to determine Intended Use; 2. If classified as a drug, guide NDC submission prep; 3. Restructure packaging layouts into Drug Facts panels; 4. Audit the facility for 21 CFR 211 pharmaceutical GMP compliance; 5. Coordinate active assay methods validation with qualified laboratories.
7. Official Sources & Last Modified
Sources: U.S. FDA Drug Registration and Listing System (DRLS), 21 CFR Part 201/211 codes, and FDA OTC Monographs. Verified as of 2026.
8. Professional Review Team Profile
Reviewed by the QTC U.S. OTC Drug & Cosmetics Compliance Committee, composed of registered pharmacists and pharma QA directors with over 15 years of FDA inspection and border clearing experience.
FAQ
What if a product (e.g. sunscreen cream) has both protection and skincare properties?+
The FDA classifies it as a dual-status product (cosmetic-drug). However, in terms of enforcement and custom checks, the FDA regulates it under the more stringent OTC drug pathway. The factory must obtain an NDC code and print a Drug Facts panel. QTC assists brands in diagnosing regulatory status before product launches.
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
